A new study published in the Canadian Journal of Cardiology, evaluated the risk for cataracts in over 200,000 patients taking statin medications in comparison to over 1 million control subjects. The study concluded that the risk for developing cataracts was increased by 27% in those individuals taking a statin in medication for one year or more, stating:
This study demonstrates that statin use is significantly associated with cataract requiring surgical intervention.
Interestingly, the study was just reviewed by the online health news service, HealthDay. In their report they interviewed Dr. Mark Fromer, an ophthalmologist at Lenox Hill Hospital in New York City, who indicated that cataracts are very common and are easy to deal with by having a “quick, painless and 99.9% successful” surgical procedure. He went on to say, “So, since you are going to get a cataract anyway, you might as well take your statin — it’s in your best interest.”
Macular degeneration is a leading cause of visual loss in elderly Americans. Worldwide, it represents one of the most common causes of irreversible blindness. To putstatistics related to macular degeneration in perspective, consider that the number of people living with macular degeneration is similar to the number of people whohave been diagnosed with all types of invasive cancers. While as many as 11 million Americans have some sort of age-related macular degeneration (AMD), even more compelling is the fact that this number is predicted to reach 22 million by the year 2050.
It has been estimated that the global cost of visual in permit related AMD is somewhere in the neighborhood of $350 billion. And unfortunately as things stand at the present time there is no cure for the most common type of AMD. There are some approaches that perhaps may slow the progression, but again, we don’t yet have any approach that can turn things around. Continue reading